201 related articles for article (PubMed ID: 2036420)
1. Comparative 2D NMR studies of human insulin and des-pentapeptide insulin: sequential resonance assignment and implications for protein dynamics and receptor recognition.
Hua QX; Weiss MA
Biochemistry; 1991 Jun; 30(22):5505-15. PubMed ID: 2036420
[TBL] [Abstract][Full Text] [Related]
2. Two-dimensional NMR studies of Des-(B26-B30)-insulin: sequence-specific resonance assignments and effects of solvent composition.
Hua QX; Weiss MA
Biochim Biophys Acta; 1991 May; 1078(1):101-10. PubMed ID: 1646635
[TBL] [Abstract][Full Text] [Related]
3. Dynamics of a monomeric insulin analogue: testing the molten-globule hypothesis.
Hua QX; Ladbury JE; Weiss MA
Biochemistry; 1993 Feb; 32(6):1433-42. PubMed ID: 8431423
[TBL] [Abstract][Full Text] [Related]
4. Toward the solution structure of human insulin: sequential 2D 1H NMR assignment of a des-pentapeptide analogue and comparison with crystal structure.
Hua QX; Weiss MA
Biochemistry; 1990 Nov; 29(46):10545-55. PubMed ID: 2271664
[TBL] [Abstract][Full Text] [Related]
5. The solution structure of a monomeric insulin. A two-dimensional 1H-NMR study of des-(B26-B30)-insulin in combination with distance geometry and restrained molecular dynamics.
Knegtel RM; Boelens R; Ganadu ML; Kaptein R
Eur J Biochem; 1991 Dec; 202(2):447-58. PubMed ID: 1761045
[TBL] [Abstract][Full Text] [Related]
6. Heteronuclear 2D NMR studies of an engineered insulin monomer: assignment and characterization of the receptor-binding surface by selective 2H and 13C labeling with application to protein design.
Weiss MA; Hua QX; Lynch CS; Frank BH; Shoelson SE
Biochemistry; 1991 Jul; 30(30):7373-89. PubMed ID: 1906742
[TBL] [Abstract][Full Text] [Related]
7. Structure and dynamics of des-pentapeptide-insulin in solution: the molten-globule hypothesis.
Hua QX; Kochoyan M; Weiss MA
Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2379-83. PubMed ID: 1549601
[TBL] [Abstract][Full Text] [Related]
8. Two-dimensional NMR and photo-CIDNP studies of the insulin monomer: assignment of aromatic resonances with application to protein folding, structure, and dynamics.
Weiss MA; Nguyen DT; Khait I; Inouye K; Frank BH; Beckage M; O'Shea E; Shoelson SE; Karplus M; Neuringer LJ
Biochemistry; 1989 Dec; 28(25):9855-73. PubMed ID: 2692717
[TBL] [Abstract][Full Text] [Related]
9. High resolution 1H-NMR studies of Des-(B26-B30)-insulin; assignment of resonances and properties of aromatic residues.
Hua QX; Chen YJ; Wang CC; Wang DC; Roberts GC
Biochim Biophys Acta; 1989 Feb; 994(2):114-20. PubMed ID: 2642711
[TBL] [Abstract][Full Text] [Related]
10. Nonlocal structural perturbations in a mutant human insulin: sequential resonance assignment and 13C-isotope-aided 2D-NMR studies of [PheB24-->Gly]insulin with implications for receptor recognition.
Hua QX; Shoelson SE; Weiss MA
Biochemistry; 1992 Dec; 31(47):11940-51. PubMed ID: 1445924
[TBL] [Abstract][Full Text] [Related]
11. Solution structure of an engineered insulin monomer at neutral pH.
Olsen HB; Ludvigsen S; Kaarsholm NC
Biochemistry; 1996 Jul; 35(27):8836-45. PubMed ID: 8688419
[TBL] [Abstract][Full Text] [Related]
12. The role of the C-terminus of the insulin B-chain in modulating structural and functional properties of the hormone.
Leyer S; Gattner HG; Leithäuser M; Brandenburg D; Wollmer A; Höcker H
Int J Pept Protein Res; 1995 Nov; 46(5):397-407. PubMed ID: 8567184
[TBL] [Abstract][Full Text] [Related]
13. High-resolution structure of an engineered biologically potent insulin monomer, B16 Tyr-->His, as determined by nuclear magnetic resonance spectroscopy.
Ludvigsen S; Roy M; Thøgersen H; Kaarsholm NC
Biochemistry; 1994 Jul; 33(26):7998-8006. PubMed ID: 8025104
[TBL] [Abstract][Full Text] [Related]
14. Two-dimensional NMR studies on des-pentapeptide-insulin. Proton resonance assignments and secondary structure analysis.
Boelens R; Ganadu ML; Verheyden P; Kaptein R
Eur J Biochem; 1990 Jul; 191(1):147-53. PubMed ID: 2199196
[TBL] [Abstract][Full Text] [Related]
15. Solution structure of the B-chain of insulin as determined by 1H NMR spectroscopy. Comparison with the crystal structure of the insulin hexamer and with the solution structure of the insulin monomer.
Hawkins B; Cross K; Craik D
Int J Pept Protein Res; 1995 Nov; 46(5):424-33. PubMed ID: 8567187
[TBL] [Abstract][Full Text] [Related]
16. The solution structure of a superpotent B-chain-shortened single-replacement insulin analogue.
Kurapkat G; Siedentop M; Gattner HG; Hagelstein M; Brandenburg D; Grötzinger J; Wollmer A
Protein Sci; 1999 Mar; 8(3):499-508. PubMed ID: 10091652
[TBL] [Abstract][Full Text] [Related]
17. Mutations at the dimer, hexamer, and receptor-binding surfaces of insulin independently affect insulin-insulin and insulin-receptor interactions.
Shoelson SE; Lu ZX; Parlautan L; Lynch CS; Weiss MA
Biochemistry; 1992 Feb; 31(6):1757-67. PubMed ID: 1737029
[TBL] [Abstract][Full Text] [Related]
18. I222 crystal form of despentapeptide (B26-B30) insulin provides new insights into the properties of monomeric insulin.
Whittingham JL; Youshang Z; Záková L; Dodson EJ; Turkenburg JP; Brange J; Dodson GG
Acta Crystallogr D Biol Crystallogr; 2006 May; 62(Pt 5):505-11. PubMed ID: 16627943
[TBL] [Abstract][Full Text] [Related]
19. Maintenance of the B-chain beta-turn in [GlyB24] insulin mutants: a steady-state fluorescence anisotropy study.
Pittman I; Nakagawa SH; Tager HS; Steiner DF
Biochemistry; 1997 Mar; 36(12):3430-7. PubMed ID: 9131992
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of allo-Ile(A2)-insulin, an inactive chiral analogue: implications for the mechanism of receptor binding.
Wan ZL; Xu B; Chu YC; Katsoyannis PG; Weiss MA
Biochemistry; 2003 Nov; 42(44):12770-83. PubMed ID: 14596591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
